glp 1 nafld Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty liver disease? Glucagon‐like peptide‐1 receptor agonists (GLP‐1

The association between quitting smoking and weight gain: a systematic review and metaanalysis of prospective cohort studies

L-

Various factors associated with the COVID-19 pandemic, such as social isolation, economic stress, uncertainty, and disruptions to daily life, were identified as potential contributors to mental health challenges

Moreno-SanchezPAGarcia-IslaGCorinoVDAVehkaojaABrukampKvan GilsMet alECG-based data-driven solutions for diagnosis and prognosis of cardiovascular diseases: a systematic review

It also supports recovery, making it beneficial for individuals engaging in resistance training or physical activity

The hazard ratios (HRs) and confidence intervals (CIs) were calculated using a stratified Cox proportional hazards model in which treatment was considered a fixed effect and trial-level cardiovascular risk as the stratification factor